Prolactin overexpression by MDA-MB-435 human breast cancer cells accelerates tumor growth.
about
Phosphorylation of tyrosine 285 of PAK1 facilitates βPIX/GIT1 binding and adhesion turnoverMiz1 deficiency in the mammary gland causes a lactation defect by attenuated Stat5 expression and phosphorylationPAK1-Nck regulates cyclin D1 promoter activity in response to prolactinA comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort.Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor.16 kDa prolactin reduces angiogenesis, but not growth of human breast cancer tumors in vivo.Autocrine prolactin inhibits human uterine decidualization: a novel role for prolactin.Expression microarray analysis reveals genes associated with in vitro resistance to cisplatin in a cell line model.What can we learn from rodents about prolactin in humans?Bioactive prolactin levels and risk of breast cancer: a nested case-control study.Adapter protein SH2B1beta binds filamin A to regulate prolactin-dependent cytoskeletal reorganization and cell motility.Prolactin upregulates its receptors and inhibits lipolysis and leptin release in male rat adipose tissueSrc tyrosyl phosphorylates cortactin in response to prolactin.Estrogen receptor-alpha expression in the mammary epithelium is required for ductal and alveolar morphogenesis in mice.Tyrosyl phosphorylated serine-threonine kinase PAK1 is a novel regulator of prolactin-dependent breast cancer cell motility and invasion.Tyrosyl phosphorylated PAK1 regulates breast cancer cell motility in response to prolactin through filamin ALarge isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer.Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity.PAK1 regulates breast cancer cell invasion through secretion of matrix metalloproteinases in response to prolactin and three-dimensional collagen IV.Regulation of prolactin receptor levels and activity in breast cancerA 20-year prospective study of plasma prolactin as a risk marker of breast cancer development.Prolactin-induced PAK1 tyrosyl phosphorylation promotes FAK dephosphorylation, breast cancer cell motility, invasion and metastasis.Prolactin confers resistance against cisplatin in breast cancer cells by activating glutathione-S-transferase.Reevaluation of the proposed autocrine proliferative function of prolactin in breast cancerHypothesis: prolactin is tumorigenic to human breast: dispelling the myth that prolactin-induced mammary tumors are rodent-specific.Prolactin and breast cancer: The need to avoid undertreatment of serious psychiatric illnesses in breast cancer patients: A review.Prolactinoma through the female life cycle.Stromal-epithelial interactions modulate cross-talk between prolactin receptor and HER2/Neu in breast cancer.A 12-month moderate-intensity exercise intervention does not alter serum prolactin concentrations.
P2860
Q27319440-FE24A314-6C04-48E6-9617-253649CC1CF6Q27321385-6EC0ACB3-434C-48CA-84C3-F0412FB2CC4BQ30425265-32E4E317-97A3-44EA-9920-8F6A582BBD2CQ33308309-4B333B7E-078A-4C7A-A774-37F49E642602Q34258777-5EF8894A-4EC5-4729-BF68-7C24CCF475D3Q34346132-9DE10AA7-6F02-40CF-A3C2-99641A30E662Q34574594-FE3766B9-2AF1-4408-B8CF-CF233A788179Q34636502-A25E6FCD-9987-4F34-8EF6-D432679EDD6EQ34721567-ECE55FE4-60DC-40A7-8E35-1607C553223EQ34964061-84BF0ED5-E915-4A42-AE88-63F0A50D477AQ35073608-ACF8AB1D-C20F-46F5-9158-F3E904C8A48DQ35830213-BA642740-8510-4CF1-AE1D-CC4E41AB541FQ35836464-6E778985-2392-40EB-8D62-EDDF99769DABQ35990241-3D12BFAB-0437-4433-BAB7-28D075B1A5A8Q36078608-601442F9-1E67-4037-B199-3E179B3F8047Q36660604-C83E9BF2-0F88-4187-B2A0-ECCF95B26717Q36678643-AC6964F2-70FF-4AC0-8076-4C7792781690Q36955129-B07B5F5E-EFBE-42A7-88F5-D4F4A6C93E33Q36998060-C2C3AA9F-456A-4DFD-B1BB-ABAEAAF7FEDDQ37060370-DEAB7732-1A3D-4FE2-9F78-341BB3E0584CQ37082963-60358653-63E2-4FE9-81D4-F4AD09758C91Q37192218-B32D7F83-8023-4A90-B368-5E97186DDD46Q37281667-0DFB42E5-A619-4BE0-A354-E1D14BE660DFQ37302064-EA4C6BED-DC46-4333-AB8B-7B7799F374CAQ37957807-6F0A8E73-20BD-432B-B575-2C989E36BFACQ38604789-4028DC5B-BE65-49A4-870E-2899E6150DECQ47572586-D881A6CA-9536-436B-B161-D67CAEC00746Q51365910-67C3CE16-011D-4C2C-963A-AD22F66D333EQ55669305-604DF7FE-4532-4D64-BD17-DC6D597A5549
P2860
Prolactin overexpression by MDA-MB-435 human breast cancer cells accelerates tumor growth.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Prolactin overexpression by MD ...... ells accelerates tumor growth.
@en
Prolactin overexpression by MD ...... ells accelerates tumor growth.
@nl
type
label
Prolactin overexpression by MD ...... ells accelerates tumor growth.
@en
Prolactin overexpression by MD ...... ells accelerates tumor growth.
@nl
prefLabel
Prolactin overexpression by MD ...... ells accelerates tumor growth.
@en
Prolactin overexpression by MD ...... ells accelerates tumor growth.
@nl
P2093
P356
P1476
Prolactin overexpression by MD ...... ells accelerates tumor growth.
@en
P2093
Bonnie Neltner
Lindsey Menchen
Lisa Mohamet
P2888
P304
P356
10.1023/A:1023956223037
P407
P577
2003-05-01T00:00:00Z
P6179
1038165629